Results 141 to 150 of about 1,974 (156)

SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma

Tumor Biology, 2014
Han Liang, Xue-Gang Luo, Jingyu Deng
exaly  

SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma

Human Pathology, 2016
En-Min Li, Li-Yan Xu, Zhiyong Wu
exaly  

Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors

ACS Medicinal Chemistry Letters, 2020
Dai-Shi Su, Caretha Creasy, Alan P Graves   +2 more
exaly  

Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy

Tumor Biology, 2016
Yu Fan, Yan Qin, Mingyue Tan
exaly  

Novobiocin decreases SMYD3 expression and inhibits the migration of MDA‐MB‐231 human breast cancer cells

IUBMB Life, 2010
Tao Xi, Shuzhen Wang
exaly  

Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer

Tumor Biology, 2015
Han Liang, Xue-Gang Luo, Jingyu Deng
exaly  

Methods of modulating SMYD3 for treatment of cancer

2007
NAKAMURA YUSUKE, FURUKAWA YOICHI, HAMAMOTO RYUJI, NAKATSURU SHUICHI   +3 more
openaire   +2 more sources

Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor

ACS Medicinal Chemistry Letters, 2016
Michael Thomenius, Nigel Waters, Robert Copeland   +2 more
exaly  

Inhibiting SMYD3 to overcome chemoresistance

2016
P. Sanese, A. Peserico, V. Celestini, R. Fittipaldi, G. Caretti, A. Del Rio, C. Simone   +6 more
openaire   +1 more source

Knockdown of SMYD3 by RNA interference inhibits cervical carcinoma cell growth and invasion in vitro

BMB Reports, 2008
Tao Xi, Xue-Gang Luo, Shuzhen Wang
exaly